圣诺生物：股东川发投资、卢昌亮、王晓莉拟合计减持不超3.43%股份

Core Viewpoint - The announcement from Shengnuo Biotech indicates that significant shareholders plan to reduce their holdings, which may impact the company's stock performance and investor sentiment [1] Shareholder Reduction Plans - Shareholder Chuanfa Investment intends to reduce its holdings by up to 4,721,578 shares, representing 3% of the company's total share capital [1] - Vice General Manager Lu Changliang plans to reduce his holdings by up to 96,579 shares, accounting for 0.0614% of the total share capital [1] - Director and Vice General Manager Wang Xiaoli plans to reduce her holdings by up to 574,696 shares, which is 0.3652% of the total share capital [1] - The reduction period is set from September 15, 2025, to December 14, 2025 [1]